ArticlebioRxiv : the preprint server for biology2026
SIGMA: SIgnaling via Golgi Morphology Analysis for pathway-state classification.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Organelle morphology is increasingly recognized as a computationally accessible readout of molecular state, yet whether subcellular architecture can identify which signaling pathway is active, not merely whether a cell is perturbed, remains untested. Here we introduce SIGMA (SIgnaling via Golgi Morphology Analysis), a framework that reframes pathway identification as a morphological classification problem centered on the Golgi apparatus. SIGMA integrates imaging flow cytometry for population-scale Golgi profiling, teacher-student knowledge distillation to transfer fine morphological cues from limited high-resolution images to an efficient lower-resolution classifier, and mechanistic generalization testing with chemically distinct activators. Applied to MRC-5 fibroblasts across six conditions spanning four signaling cascades plus controls, SIGMA achieved 90.02% cell-level accuracy and correctly assigned five of seven structurally unrelated external compounds to their expected pathway class. These results establish Golgi morphology as a multiplexed, machine-readable fingerprint of signaling state.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.